Amid President Barack Obama’s planned Precision Medicine Initiative, the U.S. Food and Drug Administration is evaluating its regulatory approach to next-generation sequencing.
The Healthcare IT Community
Start participating today.Sign-up here »
Amid President Barack Obama’s planned Precision Medicine Initiative, the U.S. Food and Drug Administration is evaluating its regulatory approach to next-generation sequencing.